HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gunhild Keller Selected Research

Gunhild Keller Research Topics

Disease

17Neoplasms (Cancer)
01/2013 - 03/2005
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2013 - 04/2008
4Melanoma (Melanoma, Malignant)
07/2008 - 07/2005
4Endometrial Neoplasms (Endometrial Cancer)
09/2005 - 04/2005
3Blast Crisis (Blast Phase)
09/2009 - 04/2008
3Breast Neoplasms (Breast Cancer)
07/2006 - 09/2005
3Lymphoma (Lymphomas)
09/2005 - 05/2005
2Neoplasm Metastasis (Metastasis)
09/2012 - 07/2005
2Aneuploidy (Aneuploid)
09/2012 - 09/2009
2Philadelphia Chromosome
05/2011 - 10/2009
2Leukemia
12/2008 - 04/2008
2Ovarian Neoplasms (Ovarian Cancer)
07/2006 - 03/2005
2Carcinoma (Carcinomatosis)
12/2005 - 03/2005
2Renal Cell Carcinoma (Grawitz Tumor)
11/2005 - 08/2005
2Body Weight (Weight, Body)
05/2005 - 04/2005
1Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
07/2012
1Pulmonary Hypertension
05/2011
1Disease Progression
09/2009
1Hepatocellular Carcinoma (Hepatoma)
09/2009

Drug/Important Bio-Agent (IBA)

7AN 204 (AN 201)IBA
07/2006 - 05/2005
7Messenger RNA (mRNA)IBA
07/2006 - 04/2005
7Proteins (Proteins, Gene)FDA Link
07/2006 - 04/2005
6Gonadotropin-Releasing Hormone (GnRH)FDA Link
07/2012 - 04/2005
5LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
07/2012 - 04/2005
5AN 215IBA
07/2006 - 03/2005
5BombesinIBA
07/2006 - 03/2005
5AN 207IBA
07/2006 - 04/2005
4Imatinib Mesylate (Gleevec)FDA Link
04/2011 - 04/2008
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
07/2006 - 05/2005
4AN 238IBA
07/2006 - 05/2005
3Tyrosine Kinase InhibitorsIBA
01/2013 - 10/2009
3danusertibIBA
09/2012 - 04/2008
3Aurora KinasesIBA
09/2012 - 12/2008
3Doxorubicin (Adriamycin)FDA LinkGeneric
07/2012 - 05/2005
2lysine(6)-doxorubicin LHRHIBA
07/2012 - 04/2005
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
07/2006 - 11/2005
2RC 121IBA
06/2006 - 05/2005
2Somatostatin Receptors (Somatostatin Receptor)IBA
06/2006 - 05/2005
2Gastrin-Releasing PeptideIBA
12/2005 - 03/2005
2Membrane Transport Proteins (Biological Pump)IBA
11/2005 - 09/2005
2somatotropin releasing hormone receptorIBA
07/2005 - 06/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2005 - 06/2005
2Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
07/2005 - 06/2005
1ProteomeIBA
01/2013
1Pharmaceutical PreparationsIBA
01/2013
1Fluorouracil (Carac)FDA LinkGeneric
09/2012
1Streptozocin (Streptozotocin)FDA Link
09/2012
1Dasatinib (BMS 354825)FDA Link
05/2011
1Phosphotransferases (Kinase)IBA
10/2009
1bosutinibIBA
10/2009
1Telomerase (Telomerase Reverse Transcriptase)IBA
09/2009
1Sorafenib (BAY 43-9006)FDA Link
09/2009
1Histones (Histone)IBA
09/2009
1PHA 680626IBA
12/2008
1bcr-abl Fusion ProteinsIBA
12/2008
1N 30IBA
07/2008
1RNA (Ribonucleic Acid)IBA
07/2008
1DNA (Deoxyribonucleic Acid)IBA
05/2008
1ChemokinesIBA
05/2008
1Peptides (Polypeptides)IBA
07/2006
1Glycoproteins (Glycoprotein)IBA
09/2005
1Triptorelin Pamoate (Trelstar)FDA Link
08/2005
1Subfamily B ATP Binding Cassette TransporterIBA
08/2005
1MZ 5-156IBA
07/2005
1Insulin-Like Growth Factor I (IGF-1)IBA
07/2005
1MZ-J-7-138IBA
07/2005
1LigandsIBA
06/2005
1Insulin-Like Growth Factor II (Somatomedin A)IBA
06/2005
1MZ-J-7-118IBA
06/2005

Therapy/Procedure

14Therapeutics
01/2013 - 06/2005
9Drug Therapy (Chemotherapy)
06/2006 - 03/2005
2Aftercare (After-Treatment)
07/2006 - 12/2005
1Conservative Treatment
09/2012
1Cell Transplantation
09/2012
1Immunotherapy
05/2008
1Investigational Therapies (Experimental Therapy)
08/2005